Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.545 USD | +14.35% | +5.24% | +2.95% |
01:31pm | HC Wainwright Starts Ovid Therapeutics With Buy Rating, $9 Price Target | MT |
03-08 | Ovid Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2024 * | 12.81M 1.02B | Sales 2025 * | 46.35M 3.69B | Capitalization | 220M 17.48B |
---|---|---|---|---|---|
Net income 2024 * | -51M -4.06B | Net income 2025 * | -23M -1.83B | EV / Sales 2024 * | 17.1 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 4.74 x |
P/E ratio 2024 * |
-4.4
x | P/E ratio 2025 * |
-10.7
x | Employees | 40 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 84.03% |
Latest transcript on Ovid Therapeutics Inc.
1 day | +6.94% | ||
1 week | +5.24% | ||
Current month | +8.69% | ||
1 month | +7.28% | ||
3 months | -13.67% | ||
6 months | -5.42% | ||
Current year | +2.95% |
Managers | Title | Age | Since |
---|---|---|---|
Jeremy Levin
CEO | Chief Executive Officer | 70 | 31/03/14 |
Jeffrey Rona
DFI | Director of Finance/CFO | 55 | 31/12/18 |
Zhong Zhong
CTO | Chief Tech/Sci/R&D Officer | - | 27/06/23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Barbara Duncan
BRD | Director/Board Member | 59 | 13/06/17 |
Bart Friedman
BRD | Director/Board Member | 79 | 22/11/15 |
Jeremy Levin
CEO | Chief Executive Officer | 70 | 31/03/14 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.00% | 34 M€ | +2.43% | - |
Date | Price | Change | Volume |
---|---|---|---|
29/04/24 | 3.32 | +7.10% | 145 879 |
26/04/24 | 3.1 | +3.68% | 80,529 |
25/04/24 | 2.99 | -5.08% | 112,117 |
24/04/24 | 3.15 | -1.56% | 113,127 |
23/04/24 | 3.2 | +1.59% | 110,579 |
Delayed Quote Nasdaq, April 29, 2024 at 08:50 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.95% | 220M | |
-2.88% | 103B | |
+1.38% | 95.28B | |
+1.46% | 22.15B | |
-16.53% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-13.20% | 16.05B | |
+5.49% | 13.68B | |
+33.58% | 12.17B |
- Stock Market
- Equities
- OVID Stock